# 중헌제약 (Joonghun Pharmaceutical Co., Ltd.)

> 중헌제약은 의약품 개발·제조 역량을 바탕으로 노화가 만드는 문제를 해결하는 한국 제약회사입니다. 전문의약품 중심의 의약품 사업과 Health Longevity 사업, 자체 R&D를 수행합니다. Joonghun Pharmaceutical is a Korean pharmaceutical company solving the problems of aging through prescription pharmaceuticals, health longevity products, and in-house R&D.

- 유효 품목허가 72건 (누적 106건), 치료 영역 8개
- 연간 생산능력: 정제 20억 정, 프리필드시린지 500만 개
- 수출국 35개국(의약품·헬스·롱제비티 솔루션 합산), 청주공장 GMP 적합판정(내용고형제 2016년 · 프리필드 주사제 2019년, 한국은 2014년 MFDS의 PIC/S 가입 이후 기준 적용), 등록특허 8건
- 본사: 서울특별시 영등포구 국회대로62길 15 / 공장: 충청북도 청주시 흥덕구 옥산산단로 28
- 연락처: 02-6928-9114, thankyou@joonghun.com
- 위 수치 기준일: 2026.07 · 1차 출처: https://www.joonghun.com/fact-sheet

이 사이트가 서버에서 내보내는 HTML은 전부 한국어입니다. 영어 표기는 브라우저에서 동작하는 언어 전환으로만 제공되므로, 자바스크립트를 실행하지 않는 수집기에는 영어 본문이 존재하지 않습니다. 영문 회사 개요는 아래 "Company overview (English)"를 참고하십시오.

## Company overview (English)

Joonghun Pharmaceutical Co., Ltd. (중헌제약) is a Korean pharmaceutical manufacturer, founded in 2005 as Joonghun Meditech and operating under its present name since 2014.

- Product approvals held: 72 currently valid (106 cumulative), across 8 therapeutic areas
- Annual capacity: 2.0 billion tablets tablets, 5 million units pre-filled syringes
- Exports shipped to 35 countries (medicines and health-longevity solutions combined)
- Cheongju plant GMP-certified line by line: oral solids in 2016, pre-filled syringes in 2019; Korean GMP has followed the PIC/S-aligned standard since MFDS acceded in 2014. Medical-device GMP, ISO 13485:2016, MDSAP
- 8 registered domestic patents
- Business lines: prescription and OTC medicines; Health Longevity (the Lorient cross-linked hyaluronic acid range and related solutions); in-house R&D
- Headquarters: 15, Gukhoe-daero 62-gil, Yeongdeungpo-gu, Seoul · Plant: 28 Oksansandan-ro, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do
- Contact: +82-2-6928-9114, thankyou@joonghun.com
- Figures as of 2026.07; primary source https://www.joonghun.com/fact-sheet

## 주요 페이지

- [홈](https://www.joonghun.com/): 사업 개요와 주요 수치
- [회사 소개](https://www.joonghun.com/about): 연혁, 경영 철학, 조직
- [팩트 시트](https://www.joonghun.com/fact-sheet): 회사 핵심 수치·인증·수출 현황 요약 (기업 정보의 1차 출처)
- [의약품 사업](https://www.joonghun.com/pharmaceuticals): 전문의약품 사업 개요
- [제품 목록](https://www.joonghun.com/products): 시판 중인 의약품 카탈로그
- [Health Longevity](https://www.joonghun.com/longevity): 노화의 변화가 드러나는 순서와, 각 단계에서 근거가 어디까지인지
- [R&D](https://www.joonghun.com/rnd): 연구개발 파이프라인과 국책과제
- [생산 시설](https://www.joonghun.com/facilities), [품질](https://www.joonghun.com/quality): 청주 공장, GMP 품질 시스템
- [글로벌](https://www.joonghun.com/global): 수출 시장
- [ESG](https://www.joonghun.com/esg): 사회공헌·환경·거버넌스
- [뉴스룸](https://www.joonghun.com/news), [채용](https://www.joonghun.com/careers), [문의](https://www.joonghun.com/contact)

기계 판독용: [sitemap.xml](https://www.joonghun.com/sitemap.xml) · [뉴스 RSS](https://www.joonghun.com/news/feed.xml) · [robots.txt](https://www.joonghun.com/robots.txt)

## 치료 영역

- [치료영역 전체](https://www.joonghun.com/areas)
- [심혈관계 (Cardiovascular)](https://www.joonghun.com/areas/cardiovascular)
- [신경계 (Nervous System)](https://www.joonghun.com/areas/nervous-system)
- [근골격계 (Musculoskeletal)](https://www.joonghun.com/areas/musculoskeletal)
- [항감염제 (Anti-Infectives)](https://www.joonghun.com/areas/antibiotics)
- [소화기·대사 (Alimentary & Metabolism)](https://www.joonghun.com/areas/digestive)
- [비뇨·생식기 (Genitourinary)](https://www.joonghun.com/areas/urinary)
- [혈액·조혈계 (Blood & Blood-Forming)](https://www.joonghun.com/areas/blood)
- [호흡기계 (Respiratory)](https://www.joonghun.com/areas/respiratory)

## 과학·기술 자료

- [사이언스 전체](https://www.joonghun.com/science)
- [염증은 관절에서 무엇을 하는가](https://www.joonghun.com/science/inflammation)
- [산에 약한 분자를 소장까지 보내는 설계](https://www.joonghun.com/science/formulation)
- [표피의 면역과 색소, 등록 특허 세 건의 범위](https://www.joonghun.com/science/pigmentation)
- [미토콘드리아와 NAD 대사, 탐색 단계의 연구 현황](https://www.joonghun.com/science/mitochondria)
- [같은 약이라는 것을 어떻게 증명하는가](https://www.joonghun.com/science/bioequivalence)
- [GMP는 왜 생겼는가](https://www.joonghun.com/science/gmp)
- [히알루론산은 왜 물을 붙잡는가](https://www.joonghun.com/science/hyaluronic-acid)
- [가교: 젤의 물성을 설계하는 일](https://www.joonghun.com/science/cross-linking)
- [노화를 세 가지로 나누어 보는 이유](https://www.joonghun.com/science/aging-biology)

## 제품

- [에팔정(에팔레스타트) (Epal Tab.)](https://www.joonghun.com/products/epal) — 에팔레스타트
- [아데노피주(아데노신트리포스페이트이나트륨삼수화물) (Adeno-P Inj.)](https://www.joonghun.com/products/adeno-p) — 아데노신트리포스페이트이나트륨삼수화물
- [액티브원액(시트룰린말산염) (Active One Soln.)](https://www.joonghun.com/products/active-one) — 시트룰린말산염
- [넥사브이정20밀리그램(에스오메프라졸마그네슘삼수화물) (Nexa-V Tab. 20mg)](https://www.joonghun.com/products/nexa-v-20mg) — 에스오메프라졸마그네슘삼수화물
- [넥사브이정40밀리그램(에스오메프라졸마그네슘삼수화물) (Nexa-V Tab. 40mg)](https://www.joonghun.com/products/nexa-v-40mg) — 에스오메프라졸마그네슘삼수화물
- [타리안정10밀리그램(베포타스틴베실산염) (Talian Tab. 10mg)](https://www.joonghun.com/products/talian-10mg) — 베포타스틴베실산염
- [락토셀캡슐(바실루스리케니포르미스균) (Lactocell Cap.)](https://www.joonghun.com/products/lactocell) — 바실루스리케니포르미스균
- [모라드정(모사프리드시트르산염수화물) (Morad Tab.)](https://www.joonghun.com/products/morad) — 모사프리드시트르산염수화물
- [라베프롤정10밀리그램(라베프라졸나트륨) (Labeprol Tab. 10mg)](https://www.joonghun.com/products/labeprol-10mg) — 라베프라졸나트륨
- [원포팜주사액(네포팜염산염) (Wonfopam Inj.)](https://www.joonghun.com/products/wonfopam) — 네포팜염산염
- [유로빅정5밀리그램(타다라필) (Urobig Tab. 5mg)](https://www.joonghun.com/products/urobig-5mg) — 타다라필
- [유로빅정10밀리그램(타다라필) (Urobig Tab. 10mg)](https://www.joonghun.com/products/urobig-10mg) — 타다라필
- [유로빅정20밀리그램(타다라필) (Urobig Tab. 20mg)](https://www.joonghun.com/products/urobig-20mg) — 타다라필
- [탐스루신서방정0.2밀리그램(탐스로신염산염) (Tamslusin SR Tab. 0.2mg)](https://www.joonghun.com/products/tamslusin-0-2mg) — 탐스로신염산염
- [탐스루신캡슐(탐스로신염산염) (Tamslusin Cap.)](https://www.joonghun.com/products/tamslusin) — 탐스로신염산염
- [콕시원캡슐100밀리그램(세레콕시브) (Coxione Cap. 100mg)](https://www.joonghun.com/products/coxione-100mg) — 세레콕시브
- [콕시원캡슐200밀리그램(세레콕시브) (Coxione Cap. 200mg)](https://www.joonghun.com/products/coxione-200mg) — 세레콕시브
- [루루카캡슐25밀리그램(프레가발린) (Luruca Cap. 25mg)](https://www.joonghun.com/products/luruca-25mg) — 프레가발린
- [루루카캡슐50밀리그램(프레가발린) (Luruca Cap. 50mg)](https://www.joonghun.com/products/luruca-50mg) — 프레가발린
- [루루카캡슐75밀리그램(프레가발린) (Luruca Cap. 75mg)](https://www.joonghun.com/products/luruca-75mg) — 프레가발린
- [루루카캡슐150밀리그램(프레가발린) (Luruca Cap. 150mg)](https://www.joonghun.com/products/luruca-150mg) — 프레가발린
- [엘로수바정5밀리그램(로수바스타틴칼슘(미분화)) (Elosuva Tab. 5mg)](https://www.joonghun.com/products/elosuva-5mg) — 로수바스타틴칼슘(미분화)
- [엘로수바정10밀리그램(로수바스타틴칼슘(미분화)) (Elosuva Tab. 10mg)](https://www.joonghun.com/products/elosuva-10mg) — 로수바스타틴칼슘(미분화)
- [엘로수바정20밀리그램(로수바스타틴칼슘(미분화)) (Elosuva Tab. 20mg)](https://www.joonghun.com/products/elosuva-20mg) — 로수바스타틴칼슘(미분화)
- [중헌세프타지딤주1그램 (Joonghun Ceftazidime Inj. 1g)](https://www.joonghun.com/products/joonghun-ceftazidime-1g) — 세프타지딤수화물*건조탄산나트륨
- [중헌세프트리악손나트륨주1그램 (Joonghun Ceftriaxone Sodium Inj. 1g)](https://www.joonghun.com/products/joonghun-ceftriaxone-sodium-1g) — 세프트리악손나트륨수화물
- [중헌세프트리악손나트륨주2그램 (Joonghun Ceftriaxone Sodium Inj. 2g)](https://www.joonghun.com/products/joonghun-ceftriaxone-sodium-2g) — 세프트리악손나트륨수화물
- [중헌세포탁심나트륨주1그램 (Joonghun Cefotaxime Sodium Inj. 1g)](https://www.joonghun.com/products/joonghun-cefotaxime-sodium-1g) — 세포탁심나트륨
- [중헌세포탁심나트륨주2그램 (Joonghun Cefotaxime Sodium Inj. 2g)](https://www.joonghun.com/products/joonghun-cefotaxime-sodium-2g) — 세포탁심나트륨
- [메르펜주500밀리그램(메로페넴수화물) (Merpen Inj. 500mg)](https://www.joonghun.com/products/merpen-500mg) — 메로페넴수화물
- [메르펜주1그램(메로페넴수화물) (Merpen Inj. 1g)](https://www.joonghun.com/products/merpen-1g) — 메로페넴수화물
- [제이티니스타틴시럽(니스타틴) (JT Nystatin Syrup)](https://www.joonghun.com/products/jt-nystatin) — 니스타틴
- [씨플록스정(시프로플록사신염산염수화물) (Ciflox Tab.)](https://www.joonghun.com/products/ciflox) — 시프로플록사신염산염수화물
- [세파큐어캡슐(세파클러수화물) (Cefacure Cap.)](https://www.joonghun.com/products/cefacure) — 세파클러수화물
- [프르나졸캡슐50밀리그램(플루코나졸) (Flunazole Cap. 50mg)](https://www.joonghun.com/products/flunazole-50mg) — 플루코나졸
- [트리파정(티로프라미드염산염) (Tripa Tab.)](https://www.joonghun.com/products/tripa) — 티로프라미드염산염
- [엘도스트캡슐300밀리그램(에르도스테인) (Eldost Cap. 300mg)](https://www.joonghun.com/products/eldost-300mg) — 에르도스테인
- [리셀정(비페닐디메틸디카르복실레이트) (Ricell Tab.)](https://www.joonghun.com/products/ricell) — 비페닐디메틸디카르복실레이트
- [중헌 알마게이트정 (Joonghun Almagate Tab.)](https://www.joonghun.com/products/joonghun-almagate) — 알마게이트
- [프리번정 (Freeburn Tab.)](https://www.joonghun.com/products/freeburn) — 건조수산화알루미늄겔/탄산마그네슘/옥세타자인
- [록캄캡슐(멜록시캄) (Locam Cap.)](https://www.joonghun.com/products/locam) — 멜록시캄
- [아세크릴정(아세클로페낙) (Acecryl Tab.)](https://www.joonghun.com/products/acecryl) — 아세클로페낙
- [나메린정(나부메톤) (Namerin Tab.)](https://www.joonghun.com/products/namerin) — 나부메톤
- [록소정(록소프로펜나트륨수화물) (Loxo Tab.)](https://www.joonghun.com/products/loxo) — 록소프로펜나트륨수화물
- [듀얼셋정 (Dualcet Tab.)](https://www.joonghun.com/products/dualcet) — 아세트아미노펜/트라마돌염산염
- [듀얼셋세미서방정 (Dualcet Semi ER Tab.)](https://www.joonghun.com/products/dualcet-semi-er) — 아세트아미노펜/트라마돌염산염
- [듀얼셋세미정 (Dualcet Semi Tab.)](https://www.joonghun.com/products/dualcet-semi) — 트라마돌염산염/아세트아미노펜
- [뉴로비아정240밀리그램(은행엽건조엑스) (Neurovia Tab. 240mg)](https://www.joonghun.com/products/neurovia-240mg) — 은행엽 건조엑스
- [도네케어정5밀리그램(도네페질염산염수화물) (Donecare Tab. 5mg)](https://www.joonghun.com/products/donecare-5mg) — 도네페질염산염수화물
- [도네케어정10밀리그램(도네페질염산염수화물) (Donecare Tab. 10mg)](https://www.joonghun.com/products/donecare-10mg) — 도네페질염산염수화물
- [리바토정10밀리그램(아토르바스타틴칼슘삼수화물) (Livato Tab. 10mg)](https://www.joonghun.com/products/livato-10mg) — 아토르바스타틴칼슘삼수화물
- [리바토정20밀리그램(아토르바스타틴칼슘수화물) (Livato Tab. 20mg)](https://www.joonghun.com/products/livato-20mg) — 아토르바스타틴칼슘수화물
- [암로디펜정(암로디핀베실산염) (Amlodipene Tab.)](https://www.joonghun.com/products/amlodipene) — 암로디핀베실산염
- [팬포틴프리필드시린지주 (Panfortin PFS)](https://www.joonghun.com/products/panfortin-pfs) — 에리트로포이에틴(EPO)
- [안티플라정(클로피도그렐황산수소염) (Antipla Tab.)](https://www.joonghun.com/products/antipla) — 클로피도그렐황산수소염
- [자바렐토정10밀리그램(리바록사반) (Xabarelto Tab. 10mg)](https://www.joonghun.com/products/xabarelto-10mg) — 리바록사반
- [자바렐토정15밀리그램(리바록사반) (Xabarelto Tab. 15mg)](https://www.joonghun.com/products/xabarelto-15mg) — 리바록사반
- [자바렐토정20밀리그램(리바록사반) (Xabarelto Tab. 20mg)](https://www.joonghun.com/products/xabarelto-20mg) — 리바록사반
- [발사르텔플러스정80/12.5밀리그램 (Valsartel Plus Tab. 80/12.5mg)](https://www.joonghun.com/products/valsartel-plus-80-12-5mg) — 발사르탄/히드로클로로티아지드
- [발사르텔플러스정160/12.5밀리그램 (Valsartel Plus Tab. 160/12.5mg)](https://www.joonghun.com/products/valsartel-plus-160-12-5mg) — 발사르탄/히드로클로로티아지드
- [텔로미탄정40밀리그램(텔미사르탄) (Telomitan Tab. 40mg)](https://www.joonghun.com/products/telomitan-40mg) — 텔미사르탄
- [텔로미탄정80밀리그램(텔미사르탄) (Telomitan Tab. 80mg)](https://www.joonghun.com/products/telomitan-80mg) — 텔미사르탄
- [사르포서방정300밀리그램(사르포그렐레이트염산염) (Sarpo SR Tab. 300mg)](https://www.joonghun.com/products/sarpo-300mg) — 사르포그렐레이트염산염
- [포스닐정150밀리그램(리세드론산나트륨일수화물) (Posnil Tab. 150mg)](https://www.joonghun.com/products/posnil-150mg) — 리세드론산나트륨일수화물
- [루플라주(히알루론산나트륨) (Lufla Inj.)](https://www.joonghun.com/products/lufla) — 히알루론산나트륨
- [트리알주(프리필드)(히알루론산나트륨) (Trial Inj.)](https://www.joonghun.com/products/trial) — 히알루론산나트륨
- [히알로제주(히알루로니다제) (Hyalose Inj.)](https://www.joonghun.com/products/hyalose) — 히알루로니다제
- [말락신정(디하이드로아르테미시닌, 피페라퀸포스페이트)(수출용) (Malaxin Tab.)](https://www.joonghun.com/products/malaxin) — 디히드로아르테미시닌/피페라퀸포스페이트
- [센티몰액 (Sentimol Solution)](https://www.joonghun.com/products/sentimol-solution) — 시트룰린말산염
- [메아릴정(글리메피리드) (Mearyl Tab.)](https://www.joonghun.com/products/mearyl) — 글리메피리드
- [중헌리바비린캡슐200밀리그램](https://www.joonghun.com/products/item-201701378) — 리바비린
- [아세라펜주(아세트아미노펜) (Aceraphen Inj.)](https://www.joonghun.com/products/aceraphen) — 아세트아미노펜
- [알레나정10밀리그램(에피나스틴염산염) (Allena Tab. 10mg)](https://www.joonghun.com/products/allena-10mg) — 에피나스틴염산염
- [포시아정10/100밀리그램(다파글리플로진,시타글립틴) (Forsia Tab. 10/100mg)](https://www.joonghun.com/products/forsia-10-100mg) — 다파글리플로진프로판디올수화물/시타글립틴인산염수화물
- [로리앙 No.2 (Lorient No.2)](https://www.joonghun.com/products/lorient-no2) — 가교 히알루론산
- [로리앙 No.4 (Lorient No.4)](https://www.joonghun.com/products/lorient-no4) — 가교 히알루론산
- [로리앙 No.6 (Lorient No.6)](https://www.joonghun.com/products/lorient-no6) — 가교 히알루론산
- [로리앙 엘레멘트 (Lorient Element)](https://www.joonghun.com/products/lorient-element) — 트라넥삼산 · 아스코르브산 · 나이아신아마이드 · 글루타치온

## 최근 소식

- [저분자 화합물 기반 NAD Boosting 플랫폼 기술 확보 추진](https://www.joonghun.com/news/nad-boosting-platform-2026) (2026-06-23)
- [팬젠 EPO 바이오시밀러의 국내 공급 파트너로 소개](https://www.joonghun.com/news/pangen-epo-domestic-partner-2026) (2026-05-19)
- [중헌제약, 2026년 상반기 국내 특허 5건 신규 등록](https://www.joonghun.com/news/patent-portfolio-2026) (2026-04-02)
- [엘살바도르 의약품 지원에 후원사로 참여](https://www.joonghun.com/news/el-salvador-medicine-donation-2026) (2026-03-27)
- [청주 공장, 의료기기 단일심사(MDSAP)·ISO 13485 품질 체계 운영](https://www.joonghun.com/news/cheongju-plant-quality) (2026-02-05)
- [로리앙, 파리 제27회 IMCAS World Congress 2026 참가](https://www.joonghun.com/news/lorient-imcas-paris-2026) (2026-02-01)
- [제13회 대한피부항노화학회 동계학술대회에서 '살롱 드 로리앙' 단독 세션 진행](https://www.joonghun.com/news/salon-de-lorient-anti-aging-congress-2026) (2026-01-26)
- [KOREA DERMA 2025에서 로리앙 학술 프로그램 진행](https://www.joonghun.com/news/lorient-korea-derma-2025) (2025-11-03)
- [듀얼셋(세미)정, 듀얼셋세미서방정, 아세라펜주 허가사항 변경명령](https://www.joonghun.com/news/label-change-20250808-dualcet-aceraphen) (2025-08-08)
- [콕시원캡슐 허가사항 변경명령](https://www.joonghun.com/news/label-change-20250804-coxione) (2025-08-04)